Showing 1,861 - 1,880 results of 3,189 for search '"vaccine"', query time: 0.07s Refine Results
  1. 1861

    Reinforcing cancer immunotherapy with engineered porous hollow mycobacterium tuberculosis loaded with tumor neoantigens by Jie Jiang, Feng-Ying Huang, Shu-Zhen Dai, Guang-Hong Tan, Ming-Hui Chen, Hengyu Chen, Wu-Ping Zheng, Ri-Hong Wu, Weijing Xie

    Published 2025-02-01
    “…Additionally, vaccination with phMTb-formulated neoantigen vaccines effectively reversed the tumor’s immune-suppressive microenvironment. …”
    Get full text
    Article
  2. 1862

    Establishment of <i>Echinococcus granulosus EgM123</i> Recombinant Gene Rabies Virus SRV<sub>9</sub> and Identification of Its Biological Characteristics by Yueqi Yang, Mengdan Hou, Guicheng Su, Xiaoyan Ma, Xiaohui Su, Kunlei Li, Songhan Liu, Luheng Xiao, Jingjing Yao, Jiahao Zhai, Xiaoying Wei, Yang Zhou, Qianqian Lai, Yuwei Dong, Jieyu Liu, Shaohua Zhai

    Published 2024-12-01
    “…The synthesized <i>EgM123</i> recombinant gene rabies virus SRV<sub>9</sub> can function as a vaccine strain for the development of the “Rabies-HD bivalent recombinant gene oral vaccine”, therefore aiding in the prevention and management of rabies and HD in animals.…”
    Get full text
    Article
  3. 1863

    Modified vaccinia virus Ankara triggers type I IFN production in murine conventional dendritic cells via a cGAS/STING-mediated cytosolic DNA-sensing pathway. by Peihong Dai, Weiyi Wang, Hua Cao, Francesca Avogadri, Lianpan Dai, Ingo Drexler, Johanna A Joyce, Xiao-Dong Li, Zhijian Chen, Taha Merghoub, Stewart Shuman, Liang Deng

    Published 2014-04-01
    “…Modified vaccinia virus Ankara (MVA) is an attenuated poxvirus that has been engineered as a vaccine against infectious agents and cancers. Our goal is to understand how MVA modulates innate immunity in dendritic cells (DCs), which can provide insights to vaccine design. …”
    Get full text
    Article
  4. 1864
  5. 1865

    Oral Immunotherapy Using Probiotic Ice Cream Containing Recombinant Food-Grade Lactococcus lactis Which Inhibited Allergic Responses in a BALB/c Mouse Model by Alireza Vasiee, Fereshteh Falah, Mojtaba Sankian, Farideh Tabatabaei-Yazdi, Seyed Ali Mortazavi

    Published 2020-01-01
    “…This study was conducted to evaluate the effects of recombinant probiotic bacteria as a candidate for oral vaccine with the potential of treating allergy to Amaranthus retroflexus pollens. …”
    Get full text
    Article
  6. 1866

    Scoping review of the applications of peptide microarrays on the fight against human infections. by Arthur Vengesai, Maritha Kasambala, Hamlet Mutandadzi, Tariro L Mduluza-Jokonya, Takafira Mduluza, Thajasvarie Naicker

    Published 2022-01-01
    “…<h4>Conclusion</h4>The most important application of peptide microarrays was found to be B-cell epitope mapping or antibody profiling to identify diagnostic and vaccine targets. Immunosignatures identified by random peptide microarrays were found to be applied in the diagnosis of infections and interrogation of vaccine responses. …”
    Get full text
    Article
  7. 1867
  8. 1868

    A Rare Case of Large-Vessel Vasculitis following Checkpoint Inhibitor Therapy and Pegfilgrastim by Joseph Mort, Shipra Maheshwari, Nayanika Basu, Patrick Dillon, Kevin Brady, Harry Bear, Trish Millard

    Published 2022-01-01
    “…We also extend the possibility of large-vessel vasculitis development in relation to the COVID-19 vaccine due to shared ingredients found in both the vaccine and pegfilgrastim. …”
    Get full text
    Article
  9. 1869

    Peptide-Based Vaccinology: Experimental and Computational Approaches to Target Hypervariable Viruses through the Fine Characterization of Protective Epitopes Recognized by Monoclon... by Matteo Castelli, Francesca Cappelletti, Roberta Antonia Diotti, Giuseppe Sautto, Elena Criscuolo, Matteo Dal Peraro, Nicola Clementi

    Published 2013-01-01
    “…Here, we review several strategies based on experimental techniques alone or addressed by in silico analysis that are frequently used to predict immunogens to be included in novel epitope-based vaccine approaches. We will list the main strategies aiming to design a new vaccine preparation conferring the protection of a neutralizing mAb combined with an effective cell-mediated response.…”
    Get full text
    Article
  10. 1870

    Reduced aggregation of the leghorn male hepatoma cell line in suspension by supplementing dextran sulfate in the media by Jung Soo Lim, Ji Soo Kim, Yugyeong Cheon, Tae Sub Park, Jong Kwang Hong

    Published 2025-02-01
    “…Objective The study aimed to improve the efficiency of leghorn male hepatoma (LMH) cells for animal virus vaccine production by transitioning from adherent to suspension culture and evaluating the effects of dextran sulfate (DS) on preventing cell aggregation. …”
    Get full text
    Article
  11. 1871
  12. 1872

    Analysis and Characterization of the Immunogenicity of Rhoptry Protein 18 by Masoud Foroutan, Amir Karimipour-Saryazdi, Ali Dalir Ghaffari, Hamidreza Majidiani, Arezo Arzani Birgani, Elaheh Karimzadeh-Soureshjani, Shahrzad Soltani, Hany M Elsheikha

    Published 2025-02-01
    “…Due to its potential as a vaccine candidate, this study aimed to characterize several properties of the T. gondii ROP18 (TgROP18) protein to support its inclusion in vaccine formulations. …”
    Get full text
    Article
  13. 1873

    Association of Major Histocompatibility Complex Polymorphism With Acute Phase Response in Broiler Chicken by Afra Vatankhah, Gholamreza Nikbakht Brujeni, Atefeh Esmailnejad

    Published 2024-11-01
    “…The antibody response to the Newcastle disease vaccine (NDV) was also measured to assess humoral mediated immunity. …”
    Get full text
    Article
  14. 1874

    Immunoprotection of mice against Schistosomiasis mansoni using solubilized membrane antigens. by Guidenn Sulbarán, Oscar Noya, Beatríz Brito, Diana E Ballén, Italo M Cesari

    Published 2013-01-01
    “…Experimental vaccination studies are however necessary to identify parasite molecules that would serve as vaccine candidates. …”
    Get full text
    Article
  15. 1875

    Antiviral and Immunoenhancing Properties of 7-Thia-8-Oxoguanosine and Related Guanosine Analogues by Donald F Smee, Howard B Cottam, Brahma S Sharma, Ganesh D Kini, Ganapathi R Revankar, Emmanuel A Ojo-Amaize, Robert W Sidwell, Weldon B Jolley, Roland K Robins

    Published 1992-01-01
    “…TOGuo also has adjuvant activity, since its use in combination with a killed Ll210 leukemia cell vaccine greatly reduced the mortality of mice inoculated with live Ll210 leukemia cells compared with the vaccine used alone. …”
    Get full text
    Article
  16. 1876

    Leveraging mRNA technology for antigen based immuno-oncology therapies by Wei Zheng, Michele Ceccarelli, Charalampos S Floudas, Siranush Sarkizova

    Published 2025-01-01
    “…While this review centers on therapeutic mRNA vaccines targeting existing tumors, it does not cover preventative vaccines. …”
    Get full text
    Article
  17. 1877

    Factors Affecting Immunization Coverage for Children Under Five Years in Rwanyamahembe Sub-County, Mbarara District- Uganda. by Omia, Santos

    Published 2023
    “…The study further identified inadequate funding of the program, perceived shortage of staff, cost of vaccination and vaccination cards, inadequate supply of vaccine stock, inadequate vaccination sites and corruption and embezzlement of funds as the main institutional factors affecting with EPI service coverage. …”
    Get full text
    Thesis
  18. 1878
  19. 1879
  20. 1880

    Immunization History of Children with Inflammatory Bowel Disease by Ing Shian Soon, Jennifer CC deBruy, Iwona Wrobel

    Published 2013-01-01
    “…BACKGROUND: Protection against vaccine-preventable diseases is important in children with inflammatory bowel disease (IBD) due to frequent immunosuppressive therapy use. …”
    Get full text
    Article